Laboratory Corp of America Holdings (LH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 1,557,000 | 618,400 | -85,300 | -316,900 | 824,900 |
| Depreciation Amortization | 1,086,800 | 901,700 | 288,500 | 144,600 | 577,200 |
| Income taxes - deferred | -47,000 | -48,500 | -29,400 | 5,100 | 29,200 |
| Accounts receivable | -955,900 | -664,700 | -183,100 | 45,600 | -123,100 |
| Accounts payable and accrued liabilities | -5,300 | 17,300 | -88,900 | -56,500 | -12,800 |
| Other Working Capital | -856,900 | -401,700 | -253,700 | -184,800 | -294,400 |
| Other Operating Activity | 1,356,600 | 938,200 | 926,400 | 566,700 | 443,700 |
| Operating Cash Flow | $2,135,300 | $1,360,700 | $574,500 | $203,800 | $1,444,700 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -40,100 | 1,000 | 1,000 | 900 | -27,500 |
| PPE Investments | -339,600 | -281,200 | -197,900 | -99,600 | -392,500 |
| Net Acquisitions | -267,600 | -208,800 | -11,300 | N/A | -874,300 |
| Purchase Of Investment | N/A | -29,300 | -21,800 | -7,900 | N/A |
| Other Investing Activity | 4,100 | 3,100 | 0 | 0 | 11,200 |
| Investing Cash Flow | $-643,200 | $-515,200 | $-230,000 | $-106,600 | $-1,283,100 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 151,700 | 151,700 | 151,700 | 151,700 | 2,395,000 |
| Debt Repayment | -563,900 | -563,900 | -151,700 | -151,700 | -2,184,900 |
| Common Stock Issued | 55,900 | 50,600 | 28,800 | 26,900 | 64,700 |
| Common Stock Repurchased | -100,000 | -100,000 | -100,000 | -100,000 | -450,000 |
| Other Financing Activity | -61,100 | -54,800 | -48,500 | -29,700 | -77,500 |
| Financing Cash Flow | $-517,400 | $-516,400 | $-119,700 | $-102,800 | $-252,700 |
| Exchange Rate Effect | 8,600 | 600 | -5,300 | -8,300 | 1,800 |
| Beginning Cash Position | 337,500 | 337,500 | 337,500 | 337,500 | 426,800 |
| End Cash Position | 1,320,800 | 667,200 | 557,000 | 323,600 | 337,500 |
| Net Cash Flow | $983,300 | $329,700 | $219,500 | $-13,900 | $-89,300 |
| Free Cash Flow | |||||
| Operating Cash Flow | 2,135,300 | 1,360,700 | 574,500 | 203,800 | 1,444,700 |
| Capital Expenditure | -381,700 | -282,300 | -205,100 | -106,600 | -400,200 |
| Free Cash Flow | 1,753,600 | 1,078,400 | 369,400 | 97,200 | 1,044,500 |